Black Friday Sale: Get 75% off a digital subscription

Pharmaceutical Industry

No good in Pfizer merger

No good in Pfizer merger

Responding to questions about whether the proposed merger of pharmaceutical giants Pfizer and Allergan is a way to reduce its corporate taxes, "Pfizer CEO Ian Read said only that company executives' obligation is to shareholders and patients" ("'Inversion' cries greet blockbuster merger," Nov. 24).

I can understand the obligation to shareholders, which has become the sole justification for every corporate attempt to wring more profit from an unprotected public, but I fail to see how this merger will help patients, much less the public...